Skip to content

Community-acquired MRSA soars among people with HIV in San Francisco

Kaletra, saquinavir have anti-malarial effects in test tube

EU survey finds widespread ignorance of HIV transmission risks

Higher baseline HCV viral load and CD4 percentage predict response to hepatitis C treatment in HIV/HCV co-infected patients

Anti-HIV therapy suppresses viral load well in older patients, but CD4 cell recovery may be impaired

Darunavir: negative interactions with Kaletra, Viagra and contraceptive pill reported

CXCR4, dual or mixed tropic HIV does not reduce response to HAART

Atazanavir/efavirenz NRTI-sparing regimen effective, but raises lipid levels

MK-0518: three-quarters of highly treated patients have undetectable viral load at 24 weeks